Clever Leaves Holdings Inc
OTC:CLVR

Watchlist Manager
Clever Leaves Holdings Inc Logo
Clever Leaves Holdings Inc
OTC:CLVR
Watchlist
Price: 0.0001 USD Market Closed
Market Cap: 175 USD

Relative Value

There is not enough data to reliably calculate the relative value of CLVR.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CLVR Relative Value
Base Case
Not Available
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
vs Industry
89
Median 3Y
0.3
Median 5Y
0.6
Industry
2.5
Forward
0
vs History
vs Industry
Median 3Y
-0.2
Median 5Y
-0.5
Industry
21.2
Forward
-0
vs History
vs Industry
Median 3Y
-0.4
Median 5Y
-0.9
Industry
16.3
vs History
vs Industry
Median 3Y
-0.3
Median 5Y
-0.6
Industry
23.8
vs History
vs Industry
80
Median 3Y
0.2
Median 5Y
0.3
Industry
2.1
vs History
vs Industry
Median 3Y
0
Median 5Y
0.2
Industry
2.6
Forward
-0.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0.6
Industry
5.2
vs History
0
vs Industry
54
Median 3Y
-0
Median 5Y
-0.5
Industry
12.5
Forward
1.2
vs History
0
vs Industry
52
Median 3Y
-0
Median 5Y
-0.4
Industry
15.9
Forward
0.6
vs History
0
vs Industry
55
Median 3Y
-0
Median 5Y
-0.4
Industry
14.6
vs History
0
vs Industry
42
Median 3Y
-0
Median 5Y
-0.4
Industry
17.2
vs History
vs Industry
Median 3Y
0
Median 5Y
0.1
Industry
1.8

Multiples Across Competitors

CLVR Competitors Multiples
Clever Leaves Holdings Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
CO
Clever Leaves Holdings Inc
OTC:CLVR
172.8 USD 0 -0 0.5 0.4
US
Eli Lilly and Co
NYSE:LLY
739.9B USD 15.1 66.6 35.8 39.1
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
US
Johnson & Johnson
NYSE:JNJ
375.3B USD 4.2 17.2 12.6 16.5
DK
Novo Nordisk A/S
CSE:NOVO B
2T DKK 6.4 18.6 12.9 14.8
CH
Roche Holding AG
SIX:ROG
203.9B CHF 3.4 24.6 9.3 10.8
CH
Novartis AG
SIX:NOVN
189.7B CHF 4.5 18.6 10.9 14.6
UK
AstraZeneca PLC
LSE:AZN
158.2B GBP 3.9 27.8 130.6 197
US
Merck & Co Inc
NYSE:MRK
203.6B USD 3.2 11.7 8.7 10.5
IE
Endo International PLC
LSE:0Y5F
163.5B USD 70.5 -56 261.3 655.3
US
Pfizer Inc
NYSE:PFE
144.3B USD 2.3 18.3 7.8 10.9
P/E Multiple
Earnings Growth PEG
CO
Clever Leaves Holdings Inc
OTC:CLVR
Average P/E: 25.4
Not Available
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
66.6
49%
1.4
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A N/A
US
Johnson & Johnson
NYSE:JNJ
17.2
27%
0.6
DK
Novo Nordisk A/S
CSE:NOVO B
18.6
18%
1
CH
Roche Holding AG
SIX:ROG
24.6
32%
0.8
CH
Novartis AG
SIX:NOVN
18.6
17%
1.1
UK
AstraZeneca PLC
LSE:AZN
27.8
36%
0.8
US
Merck & Co Inc
NYSE:MRK
11.7
17%
0.7
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -56 N/A N/A
US
Pfizer Inc
NYSE:PFE
18.3
30%
0.6
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
CO
Clever Leaves Holdings Inc
OTC:CLVR
Average EV/EBITDA: 394.2
0.5
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
35.8
30%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
3 846.3
36%
106.8
US
Johnson & Johnson
NYSE:JNJ
12.6
7%
1.8
DK
Novo Nordisk A/S
CSE:NOVO B
12.9
13%
1
CH
Roche Holding AG
SIX:ROG
9.3
5%
1.9
CH
Novartis AG
SIX:NOVN
10.9
5%
2.2
UK
AstraZeneca PLC
LSE:AZN
130.6
10%
13.1
US
Merck & Co Inc
NYSE:MRK
8.7
8%
1.1
IE
E
Endo International PLC
LSE:0Y5F
261.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
7.8
2%
3.9
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
CO
Clever Leaves Holdings Inc
OTC:CLVR
Average EV/EBIT: 1 697.5
0.4
N/A N/A
US
Eli Lilly and Co
NYSE:LLY
39.1
32%
1.2
UK
Dechra Pharmaceuticals PLC
LSE:DPH
17 702.3
98%
180.6
US
Johnson & Johnson
NYSE:JNJ
16.5
13%
1.3
DK
Novo Nordisk A/S
CSE:NOVO B
14.8
14%
1.1
CH
Roche Holding AG
SIX:ROG
10.8
6%
1.8
CH
Novartis AG
SIX:NOVN
14.6
10%
1.5
UK
AstraZeneca PLC
LSE:AZN
197
23%
8.6
US
Merck & Co Inc
NYSE:MRK
10.5
11%
1
IE
E
Endo International PLC
LSE:0Y5F
655.3
N/A N/A
US
Pfizer Inc
NYSE:PFE
10.9
10%
1.1